Saints, France

Gerard Glauert

This inventor holds 1 USPTO granted patent. Top assignee: Laboratoire L. Lafon. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerard Glauert. Retrieved from https://idiyas.com/inventor/gerard-glauert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gerard Glauert: Innovator in Therapeutic Chemistry

Introduction

Gerard Glauert is a notable inventor based in Saints, France. He has made significant contributions to the field of therapeutic chemistry, particularly through his innovative work on 1,4-dihydropyridine derivatives. His research has the potential to impact various therapeutic applications.

Latest Patents

Gerard Glauert holds 1 patent for his invention related to 1,4-dihydropyridine derivatives and their use in therapy. This patent showcases his commitment to advancing medical science and improving therapeutic options.

Career Highlights

Gerard Glauert is associated with Laboratoire L. Lafon, where he has been instrumental in research and development. His work at this laboratory has allowed him to explore new avenues in therapeutic chemistry.

Collaborations

Throughout his career, Gerard has collaborated with esteemed colleagues such as Gerard Duret and Marguerite Henry. These collaborations have enriched his research and contributed to the advancement of their shared field.

Conclusion

Gerard Glauert's innovative work in therapeutic chemistry exemplifies the impact of dedicated research and collaboration. His contributions continue to pave the way for advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…